Director Trades
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on 1300 Smiles.
RELATED STOCKHEAD STORIES
Health & Biotech
Check Up: Dimerix and ImpediMed announced breakthroughs, while earnings dominate news flow in August
Health & Biotech
ScoPo’s Powerplays: ‘Ansell is a buy’, while all eyes are on ImpediMed’s upcoming publication
News
Closing Bell: Energy shares push ASX higher
Health & Biotech
ASX Health Stocks: Nanosonics jumps almost 20% as revenue momentum picks up steam
News
ASX Small Cap Lunch Wrap: Who wants to ruin Father’s Day this year?
News
Reporting Season Round Up: Kogan surpasses $1 billion in revenue but shares dive on profit fall
News
10 at 10: These ASX stocks have hit a home run this morning
Health & Biotech
COVID-19 has hit the global dentist industry but these ASX stocks are doing fine
Health & Biotech
All of 1300 Smiles’ Jobkeeper subsidy has gone on its dividend
Tech
BNPL is gaining traction in the medical, education sectors
Health & Biotech
These small caps will be patching up their wounds, with elective surgeries back on the table from next week
News
These 16 small caps are the most expensive; and they outperformed their peers 10.5 times
Health & Biotech
Which small cap dental stocks are cavity-free and which ones are giving investors a bit of a toothache?
Tech
Tech: FlexiGroup & Splitit are climbing this morning…and they actually had news
News
There’s been a divvie bonanza this year thanks to resources and Labor’s tax proposals
Health & Biotech
Open wide and it won’t hurt as much: dental stocks and how they’re looking
Health & Biotech
